Tune Insight Enables Hospitals and Laboratories to Accelerate Precision Oncology with Privacy-Preserving AI

Tune Insight announces that its federated platform has been selected to provide secure data collaboration capabilities for NAIPO (National AI Initiative for Precision Oncology), a major Swiss initiative designed to support hospitals and laboratories in the development of artificial intelligence solutions for cancer care

NAIPO brings together leading university hospitals, regional hospitals, research institutes, and industry partners to build a secure, federated infrastructure enabling collaborative AI development across institutions. The objective is to empower clinical and research teams to leverage large-scale, multi-source health data to improve diagnostic accuracy, identify new biomarkers, and advance personalized treatment strategies in oncology.

Tune Insight’s platform allows hospitals and laboratories to analyze and train AI models across distributed datasets without centralizing or exposing sensitive patient data. Data remains fully under the control of each institution, while advanced algorithms can operate across sites through a federated approach. This overcomes long-standing barriers related to data silos, interoperability, and compliance, enabling large-scale multicenter research without compromising privacy.

For hospital IT teams, pathology and biology labs, and translational research units, the platform offers a concrete way to operationalize AI projects, connect clinical, genomic, and imaging data, and accelerate research programs while meeting strict data-protection and governance requirements.

By integrating Tune Insight’s Federated Health Platform, hospitals and laboratories are laying the foundation for a new generation of clinically relevant, trustworthy, and scalable AI applications in oncology, bridging the gap between research and real-world clinical practice.